Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zanotti

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Allergy|July 25, 2009
How much specific is the association between hymenoptera venom allergy and mastocytosis?P Bonadonna, R Zanotti, M Pagani, et al.
Allergy|April 1, 2015
Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paperP Bonadonna, M Pagani, W Aberer, et al.
Leukemia|November 4, 2006
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factorR Zanotti, A Ambrosetti, M Lestani, et al.
International Nursing Review|August 22, 2013
Nurses' preferred end-of-life treatment choices in five countriesA Coffey, G McCarthy, E Weathers, et al.
Leukemia|July 1, 2017
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosisG Martinelli, M Mancini, C De Benedittis, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Allergy|July 25, 2009
How much specific is the association between hymenoptera venom allergy and mastocytosis?P Bonadonna, R Zanotti, M Pagani, et al.
Allergy|April 1, 2015
Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paperP Bonadonna, M Pagani, W Aberer, et al.
Leukemia|November 4, 2006
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factorR Zanotti, A Ambrosetti, M Lestani, et al.
International Nursing Review|August 22, 2013
Nurses' preferred end-of-life treatment choices in five countriesA Coffey, G McCarthy, E Weathers, et al.
Leukemia|July 1, 2017
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosisG Martinelli, M Mancini, C De Benedittis, et al.
Pageof 5